Carcinoma ex pleomorphic adenoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Carcinoma ex pleomorphic adenoma
Synonyms	Malignant mixed tumor
Pronounce	N/A
Specialty	N/A
Symptoms	Lump in the salivary gland, pain, facial nerve dysfunction
Complications	Metastasis, local recurrence
Onset	Typically in adults
Duration	Variable
Types
Causes	Malignant transformation of pleomorphic adenoma
Risks	Long-standing pleomorphic adenoma, radiation exposure
Diagnosis	Histopathology, imaging studies
Differential diagnosis	Pleomorphic adenoma, adenocarcinoma, mucoepidermoid carcinoma
Prevention	Early removal of pleomorphic adenoma
Treatment	Surgical resection, radiation therapy, chemotherapy
Medication
Prognosis	Variable, depends on stage and treatment
Frequency	Rare
Deaths	N/A

Relative incidence of parotid tumors

Carcinoma ex pleomorphic adenoma is a rare type of cancer that develops from a pre-existing pleomorphic adenoma, which is a common type of benign salivary gland tumor. This condition represents a malignant transformation within a pleomorphic adenoma, leading to a more aggressive and potentially life-threatening cancer. It most frequently occurs in the parotid gland, the largest of the salivary glands, though it can also arise in other glands where pleomorphic adenomas are found.

Etiology and Pathogenesis

The exact cause of carcinoma ex pleomorphic adenoma is not fully understood. However, it is believed that genetic mutations within the pleomorphic adenoma contribute to the malignant transformation. The risk of transformation increases with the duration the pleomorphic adenoma has been present, suggesting that long-standing lesions have a higher propensity for malignant change.

Clinical Presentation

Patients with carcinoma ex pleomorphic adenoma may present with a rapidly enlarging mass, often in the region of a previously stable or slowly growing salivary gland tumor. Other symptoms may include pain, facial nerve palsy, or other signs of local invasion. Given its aggressive nature, this carcinoma may also metastasize, leading to symptoms related to distant spread.

Diagnosis

Diagnosis of carcinoma ex pleomorphic adenoma involves a combination of clinical examination, imaging studies, and histopathological analysis. Imaging techniques such as MRI or CT scans can reveal the extent of the tumor and its relationship to surrounding structures. Fine needle aspiration biopsy or surgical biopsy is essential for confirming the diagnosis, with histopathology showing both benign pleomorphic adenoma components and areas of malignant transformation.

Treatment

The mainstay of treatment for carcinoma ex pleomorphic adenoma is surgical resection with a goal of complete removal of the tumor. Given the potential for local invasion and metastasis, wide excision including clear margins is recommended. In cases where there is evidence of metastatic disease or high risk of recurrence, adjuvant therapies such as radiation therapy or chemotherapy may be considered.

Prognosis

The prognosis for carcinoma ex pleomorphic adenoma depends on several factors, including the extent of the tumor at diagnosis, the presence of metastatic disease, and the completeness of surgical resection. Early detection and treatment are crucial for improving outcomes. However, even with aggressive treatment, the risk of recurrence and metastasis remains significant, underscoring the importance of close follow-up and monitoring.

Epidemiology

Carcinoma ex pleomorphic adenoma is a rare entity, accounting for a small percentage of all salivary gland malignancies. It predominantly affects older adults, with a slight predilection for females. The incidence of malignant transformation in pleomorphic adenoma is estimated to be between 3% to 6%.

   This article is a medical stub. You can help WikiMD by expanding it!